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veins in children, it may be difficult to place 2 leads,
which are often required for physiologic pacing.
Recently steroid-eluting epicardial leads have become
available. Because improved stimulation thresholds
were described during short-term follow-up,5-12 the
longevity of these leads may be better. An improved
longevity of epicardial leads may influence the choice
for either epicardial or endocardial pacing in children.
To our knowledge, there is no study that compares the
results of the steroid-eluting epicardial leads with those
of conventional endocardial leads. Therefore we com-
pared, in children, the longevity and the pacing and
sensing characteristics of the steroid-eluting epicardial
lead with those of the conventional endocardial lead
implanted during the same time period.
Methods
Patients. Between November 1991 and October 1996, 41
children underwent implantation of 62 pacing leads consisting
of either steroid-eluting epicardial pacing leads (group I) or
conventional endocardial pacing leads (group II). Informed
B ecause of either cardiac anatomy or small size, pac-ing in children often occurs by means of epicardial
leads. The disadvantage of epicardial leads is the short-
er longevity of these leads compared with endocardial
leads, because of an increase in stimulation threshold
resulting in an exit block.1-4 The 2-year survival of con-
ventional epicardial leads in our department was 71% ±
10%, compared with 93% ± 7% for endocardial leads.2
As an alternative for epicardial leads, endocardial leads
may be used. However, because of the small size of the
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consent was obtained from each child and/or parents.
Indications for epicardial pacing leads were the presence of
congenital heart disease, simultaneous cardiac operation,
and/or weight less than 20 kg. Indications for endocardial
pacing leads were weight more than 20 kg and either normal
anatomy or anatomy suitable for endocardial pacing. Group I
consisted of 20 patients with 33 steroid-eluting epicardial
pacing leads; group II consisted of 21 patients with 29 con-
ventional endocardial pacing leads. Seventeen children in
group I and 10 children in group II had undergone, previous-
ly (n = 11 children) or simultaneously (n = 6 children), pal-
liative (n = 2 children) or corrective (n = 15 children) opera-
tions for the congenital heart disease. Patient characteristics
are shown in Table I. There was no difference in patient char-
acteristics between the 2 groups, except for the age at implan-
tation and the presence of congenital heart disease. Long QT
syndrome, as indication for pacing, occurred more often in
group II (Table I). Once each year, a check-up at the pediatric
outpatient clinic (including a 24-hour ambulatory monitor-
ing) was performed.
Pacemaker leads. Group I consisted of 15 atrial leads (12
Medtronic 10366, 2 Medtronic SP 2139, 1 Medtronic 2823;
Medtronic, Inc, Minneapolis, Minn) inserted via sternotomy
(n = 7 leads), lateral thoracotomy (n = 7 leads), or subxiphoid
approach (n = 1 lead) and 18 ventricular leads (14 Medtronic
10366, 2 Medtronic SP 2139, 2 Medtronic 2823 [Medtronic,
Inc]) inserted via sternotomy (n = 6 leads), lateral thora-
cotomy (n = 6 leads), or subxiphoid approach (n = 6 leads).
Group II consisted of 15 atrial leads (6 Intermedics 438-01, 4
Intermedics 438-05, 1 Intermedics 432-02, 1 Intermedics
435-02, 1 Intermedics 438-10; Intermedics, Inc, Angleton,
Tex; 2 Siemens Elema 1028T; Pacesetter, Inc, Sylmar, Calif)
inserted through the subclavian or cephalic vein (n = 14
leads) or transmurally (n = 1 lead) and 14 ventricular leads (4
Intermedics 430-02, 3 Intermedics 430-10, 2 Intermedics
431-04, 2 Intermedics 425-13, 2 Intermedics 438-05, 1
Intermedics 403-07; Intermedics, Inc) inserted through the
subclavian or cephalic vein (n = 12 leads) or transmurally (n
= 2 leads). Except for 4 unipolar leads in group I and 5 leads
in group II, all the leads were bipolar. In group II, 13 leads
had an active fixation (screw in) and 16 had a passive fixation
(tined).
Surgical technique. The epicardial leads (mostly bipolar)
were inserted by standard surgical techniques either through
a lateral thoracotomy, a midline sternotomy, or a subxiphoid
approach, whatever seemed appropriate considering heart
morphologic condition and/or previous cardiac operation.
The bipolar steroid-eluting epicardial leads consist of 2
patches with electrodes (platinized, porous, cathode 6.0 mm2;
anode 14.0 mm2). Both electrode ends were fixed on the epi-
cardium with two 6-0 Prolene sutures (Ethicon, Inc,
Somerville, NJ) for each electrode. Care was taken to fix the
electrode ends in such a way that they could not dislocate.
The smaller electrode (cathode) was fixed closest to the sinus
node (atrial position) or on the best available site on the ven-
tricle, often on the diaphragmatic site of the right ventricular
surface, which is almost always free of epicardial fibrosis
after previous cardiac operation. The other electrode (anode)
was fixed at least 1 cm from the other electrode, which was
sometimes challenging in small babies. The surplus of length
is dealt with by making wide loops of the electrode within the
pericardium and within the pacemaker pocket. In small
babies, it might be necessary to open both rectal sheaths to
create a large enough pacemaker pocket. The pacemaker box
and redundant electrode were placed behind the rectal mus-
cle. Endocardial leads were inserted through the cephalic (by
direct access) or subclavian (by puncture and with a remov-
able sheath) vein. Occasionally an endocardial lead was
introduced transmurally by passing the electrode through the
wall of the appropriate cardiac chamber, fixing it with a
purse-string suture.
Lead function analysis. The acute measurements were
performed with a Pacing System Analyzer (PSA 5311;
Medtronic, Inc). Stimulation voltage thresholds were mea-
sured with a pulse width of 0.5 ms. Sensing thresholds were
measured by filtered P and R wave amplitudes. Slew rates
and impedances were measured. During follow-up (1 day, 6
weeks, and 3 months after implantation and every 6 months
thereafter) the minimum energy threshold in microjoules (1
microjoule = (volts)2 · milliseconds · 1000/Ω) to standardize
the measurements of stimulation thresholds was used.5 P and
R wave amplitudes and impedances were performed at each
visit. P wave amplitudes of more than 3.5 mV were noted as
4 mV, and R wave amplitudes of more than 7 mV were noted
as 8 mV.
Statistical analysis. Data are expressed as mean ± SD. Log
rank test and Kaplan-Meier product-limit estimates of sur-
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Table I. Patient and pacing characteristics of steroid-
eluting epicardial (group I) and endocardial leads
(group II)
Steroid-eluting Conventional 
epicardial endocardial 
leads: leads:
group I group II 
(n = 33) (n = 29) P value
No. of patients 20 21
Age at implantation 7.6 ± 6.5 11.7 ± 4.7 .02
(y)
M/F 9/11 11/10 .64
CHD (no/yes) 3/17 10/11 .01
Indications
Congenital AV block 5 6 .80
Surgical AV block 8 3 .06
Sick sinus syndrome 6 6 .92
Long QT syndrome 0 6 .01
Other 1 0 .30
Lead atrial/ventricular 15/18 15/14 .62
pocket
Abdominal/subpectoral 20/0 3/18 <.001
Follow-up (y) 2.9 ± 1.6 3.1 ± 1.7 .61
Failure (n) 4 4 .85
CHD, congenital heart disease; AV, atrioventricular.
vival curves were used for longevity of leads. Patient deaths
were considered as lost to follow-up. To compare patient
characteristics, we used the Student t test or a c 2 test. To com-
pare pacing and sensing characteristics during the follow-up,
we used repeated measurements of analysis of variance, fol-
lowed by the Student t test for paired values. The analysis
was performed with a statistical computer program (NCSS,
Kaysville, Utah).
Results
Patients. Three patients (1 patient in group I and 2
patients in group II) had a large increase in stimulation
threshold in the early postoperative period, which was
treated with prednisone orally (2 mg/kg per day). In all
3 patients, the stimulation thresholds decreased within
a few weeks and remained low. In group I, 1 child with
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Fig 1. Lead survival (A), stimulation thresholds (B), sensing thresholds (C), and impedances (D) of steroid-elut-
ing epicardial versus conventional endocardial pacing leads. The numbers in the panels indicate the number of
observations at that point. For graphic reasons, SD is in B only shown for ventricular leads, and in D only for atri-
al leads. *P < .05, group I vs group II. Open circle, steroid-eluting epicardial leads; closed circle, endocardial
leads; open diamond, atrial steroid-eluting epicardial leads; closed diamond, atrial endocardial leads; open
square, ventricular steroid-eluting epicardial leads; closed square, ventricular endocardial leads.
a congenital complete atrioventricular block and
severe cardiomyopathy died of ventricular fibrillation
2.5 years after implantation of the epicardial lead. In
group II, 1 child with complex congenital heart disease
died of fungal endocarditis with multiorgan failure 1
year after implantation of the transvenous lead.
Lead survival. The 2-year survival of the leads was
similar between the 2 groups (group I, 91% ± 5%;
group II, 86% ± 7%; P = .97; Fig 1, A). The mean fol-
low-up was 2.9 ± 1.6 years in group I and 3.1 ± 1.7
years in group II (P = .61). The number of lead failures
was 4 in both groups (P = .85). All failures occurred in
bipolar leads. In group I, 1 lead had to be removed
because of a pocket infection, and the other 3 leads had
to be removed because of an exit block (1 week, 0.5
year, and 5.75 years after implantation). The exit block
1 week after implantation occurred in a child in whom
a previous epicardial screw lead had left numerous
scars in the epicardium. In group II, 1 lead had to be
removed because of a pocket infection; 2 leads had to
be removed because of an exit block (1 and 1.5 years
after implantation), and 1 lead had to be removed
because of a broken connection between the lead and
the header of the pacemaker. When we exclude the 2
pocket infections from the data of the survival analysis,
the 2-year survival remains similar between the 2
groups (93% ± 5% vs 87% ± 7%; P = .94). The pacing
and sensing characteristics of the mentioned 2 leads in
the patients with a pocket infection were not incorpo-
rated in the long-term measurements.
Pacing characteristics 
Acute. The acute stimulation voltage thresholds (1.0 ±
0.4 V in group I vs 0.8 ± 0.3 V in group II; P = .40), the
minimum energy thresholds (1.2 ± 1.4 m J vs 1.3 ± 1.3
m J; P = .82), and the slew rates (1.2 ± 1.7 V/s vs 0.8 ±
0.4 V/s; P = .40) of the atrial leads were similar in the
two groups. 
The acute stimulation voltage thresholds were higher in
group I than in group II (1.2 ± 0.5 V vs 0.7 ± 0.2 V; P =
.02). Both the minimum energy thresholds of the ventric-
ular leads (1.2 ± 1.3 m J vs 0.7 ± 0.4 m J; P = .17) and the
slew rates (1.8 ± 1.1 V/s vs 1.2 ± 0.6 V/s; P = .12) of the
ventricular leads were similar. 
Chronic. There was an increase in stimulation thresh-
olds of all leads in both groups in the early postopera-
tive period. This was less for the steroid-eluting epicar-
dial leads. Later during follow-up, there was no
difference in stimulation thresholds between the two
groups (Fig 1, B). During follow-up the stimulation
thresholds did not increase in either group.
Sensing characteristics
Acute. The sensed P wave amplitudes were lower in
group I than in group II (2.3 ± 1.6 mV vs 3.6 ± 0.9 mV;
P = .02). The sensed R wave amplitudes were similar
in the two groups (13.1 ± 7.8 mV vs 12.1 ± 3.3 mV; P
= .44). 
Chronic. During follow-up there was no statistically
significant difference in sensing thresholds of P and R
waves between the 2 groups (Fig 1, C). After an initial
artificial decrease, caused by the difference in the tech-
nique of measurement, the sensing threshold of the R
wave remained similar in the two groups. All sensing
problems, detected during 24-hour ambulatory moni-
toring in both groups, could be solved by changing the
pacemaker sensitivity settings.
Impedances
Acute. Atrial impedances tended to be higher in
group I (723 ± 227 Ω vs 609 ± 122 Ω; P = .07).
Ventricular impedances were higher in group I (993 ±
333 Ω vs 507 ± 157 Ω; P = .0004). 
Chronic. Atrial impedances were lower in group I
than in group II (Fig 1, D). There was no difference in
ventricular impedances between the two groups during
follow-up. All measured values of impedances were
within the normal range.
Discussion
Steroid-eluting epicardial versus conventional
endocardial leads. The results of this study show that
the longevity of steroid-eluting epicardial pacing leads
is similar to that of conventional endocardial pacing
leads implanted during the same time period. The 2-
year survival of the steroid-eluting epicardial leads was
better than the previously described 2-year survival of
non–steroid–eluting epicardial leads in our department,
which was 71% ± 10%.2 Fortunately, we did not
encounter that high incidence of exit blocks in our
steroid-eluting epicardial leads as described by Beder
and associates,13 who found an exit block in 3 of 11
patients. Cutler and colleagues14 found no exit block in
22 patients with steroid-eluting epicardial pacing elec-
trodes, which were studied for up to 6 years. Because
of the similar longevity and pacing and sensing charac-
teristics between the 2 leads found in our patients,
steroid-eluting epicardial leads may be a good alterna-
tive to endocardial leads.
Choice of pacing lead at implantation. Although for
some children the choice of pacing leads is limited to
epicardial leads (eg, after an operation such as a total
cavopulmonary connection), for most children the
choice of pacing leads can be in favor of either an epi-
cardial or an endocardial lead. The choice of pacing
lead was based primarily on the age of the child; young
children received an epicardial lead, whereas older chil-
dren received an endocardial lead. However, because
the results of endocardial leads were better than those of
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non–steroid–eluting epicardial leads,1,2 there is a ten-
dency to implant endocardial leads at a younger age.
The results of our study show that steroid-eluting epi-
cardial leads are as good as endocardial leads. Therefore
the choice of the pacing lead will be determined mainly
by the advantages and disadvantages of either implanta-
tion technique. Advantages of epicardial leads are the
applicability in every child, the possibility to combine
the implantation of the leads with a corrective or pallia-
tive operation, fewer problems with the growth of the
child, and the absence of the need for anticoagulation in
children with a right-to-left shunt. Disadvantages of epi-
cardial leads are the more extensive surgical procedure
and the damage to the epicardial wall, which may result
in difficulty in finding epicardium without scars for
implantation of another epicardial lead. An advantage of
endocardial leads is the less extensive surgical proce-
dure. Disadvantages of endocardial leads are the small
size of the veins, the risk of venous obstruction,15 and
the need for the accommodation of the lead to the
child’s growth.
Choice of pacing lead for the future. The advan-
tages and disadvantages relate to the period of implan-
tation of the leads. Although the results of transvenous
endocardial pacing in young infants are encourag-
ing,16,17 we also have to consider the consequences of
the choice of the lead for the future. Particularly in
young children who will need pacing for the whole of
their lives, it can be expected that multiple subsequent
leads will be required. Although the methods for
extraction of pacing leads are improving,18 serious
complications of the extraction procedure have been
described, and sometimes a heart operation is
required.19 When lead extraction fails, a situation with
multiple leads in 1 vein in a child, who was in need of
pacing from birth, may occur. Multiple leads in the
same vein may result in several complications, such as
an increased risk of venous obstruction15 and an inabil-
ity of the surgeon to insert new additional leads, when
necessary. Because our study shows that steroid-eluting
epicardial leads are a good alternative to endocardial
leads, it would perhaps be reasonable to pace children
epicardially as long as possible and save their veins for
a period later during lifetime.
Study limitations. A limitation of this study is the
relatively short follow-up time. However, this also
applies for the studies with endocardial leads in young
infants.16,17 A disadvantage of the steroid-eluting epi-
cardial leads in this study was the lower impedances of
the atrial leads during follow-up, which means that
more energy may be required for pacing, which could
limit the longevity of the pacemaker unit. The follow-up
time in our study was too short to evaluate the longevi-
ty of the pacemaker unit. Perhaps new designs of the
steroid-eluting epicardial leads with smaller surfaces of
the electrodes may improve impedance values in chil-
dren, because animal studies have shown that the
impedances of these leads remained high during a fol-
low-up of 6 months.8 Further longitudinal studies are
needed to compare steroid-eluting epicardial leads with
endocardial leads in young infants to answer the ques-
tion of which pacing lead implanted in infancy will have
a reduced complication rate during adulthood. In addi-
tion, it can be worthwhile to investigate whether the use
of steroid-eluting endocardial pacing leads in children
may improve the results of endocardial pacing further.
Conclusions
We conclude that the longevity of steroid-eluting epi-
cardial pacing leads in children is similar to that of the
conventional endocardial pacing leads. Pacing and
sensing thresholds were similar and did not change
during follow-up. We therefore prefer the use of
steroid-eluting epicardial leads to endocardial pacing
leads in infants and small children because they need to
be paced for the whole of their lives.
We thank A. H. van Kampen-Panjer for assistance in col-
lecting the technical data of the pacemaker follow-up mea-
surements and J. R. G. Kuipers (Head of the Division of
Pediatric Cardiology) for his assistance in preparing the
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